Literature DB >> 17089079

Urinary hesitancy and retention during treatment with sertraline.

L Lowenstein1, E R Mueller, S Sharma, M P FitzGerald.   

Abstract

We report the cases of two women who began to experience urinary hesitancy and retention after starting treatment with sertraline for depression. Discontinuation of the drug resulted in complete symptom relief. Serotonergic neurons are involved at several levels in control of the lower urinary tract. Retention is apparently an uncommon complication of sertraline. Discontinuation should be considered for patients presenting with voiding difficulties.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17089079     DOI: 10.1007/s00192-006-0241-4

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  14 in total

1.  Urinary retention with sertraline, haloperidol, and clonazepam combination.

Authors:  F Benazzi
Journal:  Can J Psychiatry       Date:  1998-12       Impact factor: 4.356

2.  Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression.

Authors:  F W Reimherr; G Chouinard; C K Cohn; J O Cole; T M Itil; Y D LaPierre; H L Masco; J Mendels
Journal:  J Clin Psychiatry       Date:  1990-12       Impact factor: 4.384

3.  Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients.

Authors:  C K Cohn; R Shrivastava; J Mendels; J B Cohn; L F Fabre; J L Claghorn; E C Dessain; T M Itil; A Lautin
Journal:  J Clin Psychiatry       Date:  1990-12       Impact factor: 4.384

4.  Facilitatory neuromodulative effect of duloxetine on pudendal motor neurons controlling the urethral pressure: a functional urodynamic study in healthy women.

Authors:  Sönke Boy; André Reitz; Barbara Wirth; Peter A Knapp; Peter M Braun; Axel Haferkamp; Brigitte Schurch
Journal:  Eur Urol       Date:  2006-01-18       Impact factor: 20.096

Review 5.  Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.

Authors:  P Mariappan; Z Ballantyne; J M O N'Dow; A A Alhasso
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

6.  Urinary Side Effects of Duloxetine in the Treatment of Depression and Stress Urinary Incontinence.

Authors:  Lars Viktrup; Beth A. Pangallo; Michael J. Detke; Norman R. Zinner
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

7.  The role of 5-HT(1A) receptors in control of lower urinary tract function in cats.

Authors:  Karl B Thor; Mary A Katofiasc; Hansjorg Danuser; Johannes Springer; John M Schaus
Journal:  Brain Res       Date:  2002-08-16       Impact factor: 3.252

8.  Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.

Authors:  R J Millard; K Moore; R Rencken; I Yalcin; R C Bump
Journal:  BJU Int       Date:  2004-02       Impact factor: 5.588

9.  Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo.

Authors:  L F Fabre; F S Abuzzahab; M Amin; J L Claghorn; J Mendels; W M Petrie; S Dubé; J G Small
Journal:  Biol Psychiatry       Date:  1995-11-01       Impact factor: 13.382

10.  Serotonergic modulation of spinal ascending activity and sacral reflex activity evoked by pelvic nerve stimulation in cats.

Authors:  M J Espey; H J Du; J W Downie
Journal:  Brain Res       Date:  1998-07-06       Impact factor: 3.252

View more
  3 in total

1.  Are commonly used psychoactive medications associated with lower urinary tract symptoms?

Authors:  Susan A Hall; Nancy N Maserejian; Carol L Link; William D Steers; John B McKinlay
Journal:  Eur J Clin Pharmacol       Date:  2011-12-04       Impact factor: 2.953

2.  Female voiding dysfunction: prevalence and common associations.

Authors:  Bernard T Haylen
Journal:  Curr Urol Rep       Date:  2009-11       Impact factor: 3.092

3.  Serotonin syndrome presenting as surgical emergency: A report of two cases.

Authors:  Sanjay Prakash; Chaturbhuj Rathore
Journal:  Indian J Crit Care Med       Date:  2016-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.